Halozyme Therapeutics Non-GAAP EPS of $1.60 beats by $0.08, revenue of $376.71M beats by $17.66M (NASDAQ:HALO)
奥洛兹美奥洛兹美(US:HALO) Seeking Alpha·2026-05-12 04:04

新闻内容技术性访问障碍 - 用户浏览器设置可能导致无法正常访问新闻内容 包括未启用Javascript和cookies [1] - 用户浏览器启用的广告拦截插件可能导致访问流程被阻断 [1]

Halozyme Therapeutics Non-GAAP EPS of $1.60 beats by $0.08, revenue of $376.71M beats by $17.66M (NASDAQ:HALO) - Reportify